Advances in Sjögren’s Syndrome Treatment For individuals living with Sjögren’s syndrome, finding effective, long-term management strategies is a primary goal. Recently, Novartis announced encouraging two-year data from their clinical trials regarding ianalumab, an investigational treatment targeting this challenging autoimmune condition. Understanding the Study Results The clinical trial data presented at the American College of Rheumatology…